Health care industry

FILE - This Jan. 25, 2019, file photo shows the Hacienda HealthCare facility in Phoenix. The long-term care facility in Arizona is shutting down a unit where an incapacitated woman was raped and later gave birth, officials with Hacienda HealthCare announced Thursday, Feb. 7, 2019. Hacienda officials say they're working with state agencies to develop a plan to move the remaining 37 patients to other facilities. (AP Photo/Matt York, file)
February 07, 2019 - 7:07 pm
PHOENIX (AP) — A long-term care facility in Arizona where an incapacitated woman was raped and later gave birth announced Thursday that it would shut down operations. Officials with Hacienda HealthCare said its board of directors determined it's not sustainable to keep operating its intermediate...
Read More
FILE - This Jan. 25, 2019, file photo shows the Hacienda HealthCare facility in Phoenix. The Arizona Legislature may boost state oversight of Hacienda HealthCare, the facility where an incapacitated woman was raped and later gave birth. (AP Photo/Matt York, file)
February 06, 2019 - 5:12 pm
PHOENIX (AP) — Arizona may boost state oversight of long-term care facilities like the one in Phoenix where an incapacitated woman was raped and later gave birth, reversing a decision more than 20 years ago to drop state regulation. Lawmakers are considering legislation that would require...
Read More
February 06, 2019 - 2:37 pm
PHILADELPHIA (AP) — Pennsylvania's health department says Ebola has been ruled out as the cause of a patient's illness at a Philadelphia hospital. Penn Medicine had said the patient at the Hospital of the University of Pennsylvania was being tested for the potentially deadly illness even though...
Read More
FILE - In this Jan. 16, 2019, file photo Sen. Bernie Sanders, I-Vt., attends a hearing on Capitol Hill in Washington. Some of the 2020 Democratic presidential hopefuls are forging ahead with “Medicare-for-all,” but others are taking a more cautious approach. Proponents like Sanders, hold out the promise of health care as right, the potential for national savings, and no more copays, deductibles or surprise medical bills.(AP Photo/Andrew Harnik, File)
February 04, 2019 - 4:42 pm
WASHINGTON (AP) — "Medicare-for-all" is quickly becoming a rallying cry for many Democratic White House hopefuls, but there are growing questions about how to pull off such a dramatic switch to a government-run health care system. The debate over scrapping private insurers has heated up in recent...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
February 01, 2019 - 12:16 pm
WASHINGTON (AP) — The Trump administration's top health official asked Congress on Friday to pass its new prescription drug discount plan and provide it to all patients, not just those covered by government programs like Medicare. The plan would take now-hidden rebates among industry players like...
Read More
FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports earnings Friday, Feb. 1, 2019. (AP Photo/Seth Wenig, File)
February 01, 2019 - 7:58 am
Higher medicine sales and lower restructuring and other costs lifted drugmaker Merck to a $1.83 billion profit in the fourth quarter, as it edged past Wall Street expectations. The maker of blockbuster cancer drug Keytruda and Januvia diabetes pills lost $1.05 billion a year earlier, when it had a...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
January 31, 2019 - 5:24 pm
WASHINGTON (AP) — The Trump administration Thursday unveiled a plan to channel now-hidden prescription drug discounts directly to patients, saying that would eventually lower prices for consumers. The proposed regulation from Health and Human Services Secretary Alex Azar aims to eliminate behind-...
Read More
Trader Michael Unkonis, center, works on the floor of the New York Stock Exchange, Tuesday, Jan. 29, 2019. Stocks are opening slightly higher on Wall Street as several big U.S. companies reported solid results for the latest quarter. (AP Photo/Richard Drew)
January 29, 2019 - 2:44 pm
NEW YORK (AP) — Major U.S. stock indexes were mostly lower late Tuesday afternoon, placing the market on course for its second decline in a row. Losses in technology and media companies outweighed gains in industrial and health care stocks. Early gains faded as investors assessed a mixed bag of...
Read More
Sen. Chuck Grassley, R-Iowa, center, chairman of the Senate Finance Committee, is joined at left by Sen. Ron Wyden, D-Ore., the ranking member, at a hearing on the high price of prescription drugs, on Capitol Hill in Washington, Tuesday, Jan. 29, 2019. (AP Photo/J. Scott Applewhite)
January 29, 2019 - 11:14 am
WASHINGTON (AP) — A senior Republican lawmaker said Tuesday he plans to investigate price spikes in the cost of insulin for people with diabetes as Congress opened hearings on the high cost of prescription drugs. "I have heard stories about people reducing their life-saving medicines, like insulin...
Read More
FILE- This Dec. 4, 2017, file photo shows a tablet of Pfizer's Viagra, left, and the company's generic version, sildenafil citrate, at Pfizer Inc., headquarters in New York. Pfizer Inc. reports earnings Tuesday, Jan. 29, 2019. (AP Photo/Richard Drew, File)
January 29, 2019 - 7:18 am
NEW YORK (AP) — Pfizer lost $394 million in the fourth quarter as it booked billions in charges for layoffs and losses related to the acquisition of a trouble-plagued business that makes sterile injectable medicines. The world's biggest drugmaker posted a $12.3 billion profit during the same period...
Read More

Pages